Procter & Gamble (NYSE:PG) Stock Price Down 1.5% - What's Next?

Key Points

• Procter & Gamble shares fell 1.5% to about $156.97 in mid-day trading, with volume slightly above average.
• The company’s defensive appeal remains supported by its 70th consecutive annual dividend increase, but investors are focused on upcoming earnings and whether volume growth can offset pricing pressure and protect margins.
• Analyst sentiment is generally favorable, with a “Moderate Buy” consensus and an average price target of $162.20, though options activity signals expectations for potential post-earnings weakness.

Procter & Gamble Company (The) (NYSE:PG - Get Free Report) dropped 1.5% during mid-day trading on Wednesday. The stock traded as low as $156.80 and last traded at $156.9660. Approximately 9,920,264 shares traded hands during trading, an increase of 2% from the average session volume of 9,690,052 shares. The stock had previously closed at $159.32.

Key Headlines Impacting Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Procter & Gamble continues to appeal to income-focused investors after raising its dividend for the 70th consecutive year. Its $1.0885-per-share quarterly payout and dependable cash flow reinforce PG’s defensive appeal, particularly while interest rates remain elevated. Procter & Gamble Expects 1% to 3% Organic Growth
• Positive Sentiment: Royal Bank of Canada reaffirmed its “outperform” rating and maintained a $166 price target, implying additional upside based on the referenced share price. RBC Reaffirms Procter & Gamble Rating
• Neutral Sentiment: Analysts are focused on PG’s third-quarter results, including sales, earnings, organic growth and management’s outlook. Investors will be looking for evidence that improving volumes can offset weaker pricing and determine whether the company’s expected 1%–3% organic-growth range is sufficient. What to Expect From Procter & Gamble’s Q3 Earnings
• Neutral Sentiment: Pre-earnings analysis highlights a core tradeoff: volume recovery would support revenue momentum, but continued pricing pressure could weigh on margins and earnings. Procter & Gamble Earnings Preview
• Negative Sentiment: Options-market activity indicates traders expect PG shares to decline following the earnings release, reflecting uncertainty around the results and guidance. That positioning is likely contributing to cautious trading ahead of the report. Barchart Data Ahead of Procter & Gamble Earnings

Analyst Ratings Changes

A number of brokerages have weighed in on PG. Argus lowered Procter & Gamble from a "buy" rating to a "hold" rating in a report on Friday, August 7th. Sanford C. Bernstein reissued a "market perform" rating and set a $149.00 target price on shares of Procter & Gamble in a research note on Monday, August 24th. UBS Group reissued a "buy" rating on shares of Procter & Gamble in a report on Friday, October 16th. Jefferies Financial Group lifted their price target on Procter & Gamble from $177.00 to $179.00 and gave the company a "buy" rating in a research note on Friday, June 26th. Finally, Royal Bank Of Canada restated an "outperform" rating and issued a $166.00 price target on shares of Procter & Gamble in a research note on Tuesday. Fourteen investment analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. According to data from MarketBeat, Procter & Gamble currently has an average rating of "Moderate Buy" and an average price target of $162.20.

Procter & Gamble Price Performance

The stock's fifty day moving average price is $147.39 and its 200-day moving average price is $146.73. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.47 and a current ratio of 0.68. The firm has a market cap of $364.58 billion, a PE ratio of 23.71, a P/E/G ratio of 3.92 and a beta of 0.39.

Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings data on Wednesday, July 29th. The company reported $1.43 EPS for the quarter, beating the consensus estimate of $1.41 by $0.02. The firm had revenue of $21.20 billion during the quarter, compared to analysts' expectations of $21.38 billion. Procter & Gamble had a net margin of 18.44% and a return on equity of 31.36%. The business's revenue for the quarter was up 1.5% compared to the same quarter last year. During the same quarter last year, the business earned $1.48 earnings per share. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. As a group, equities analysts forecast that Procter & Gamble Company will post 6.98 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, November 16th. Shareholders of record on Friday, October 23rd will be issued a $1.0885 dividend. The ex-dividend date of this dividend is Friday, October 23rd. This represents a $4.35 dividend on an annualized basis and a yield of 2.8%. Procter & Gamble's dividend payout ratio (DPR) is 65.71%.

Insider Activity at Procter & Gamble

In related news, CAO Matthew W. Janzaruk sold 359 shares of the firm's stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $145.24, for a total value of $52,141.16. Following the completion of the transaction, the chief accounting officer directly owned 1,271 shares of the company's stock, valued at $184,600.04. This trade represents a 22.02% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Marc S. Pritchard sold 4,030 shares of the firm's stock in a transaction that occurred on Thursday, August 20th. The shares were sold at an average price of $143.79, for a total value of $579,473.70. Following the completion of the transaction, the insider directly owned 187,001 shares of the company's stock, valued at $26,888,873.79. The trade was a 2.11% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last 90 days, insiders sold 15,135 shares of company stock worth $2,189,970. 0.23% of the stock is currently owned by company insiders.

Institutional Trading of Procter & Gamble

A number of institutional investors have recently bought and sold shares of the company. Mowery & Schoenfeld Wealth Management LLC acquired a new stake in shares of Procter & Gamble in the second quarter valued at approximately $26,000. Montgomery Financial Services LLC purchased a new position in shares of Procter & Gamble during the 2nd quarter worth approximately $28,000. Paladin Partners LLC acquired a new position in shares of Procter & Gamble during the 2nd quarter worth approximately $29,000. Toews Corp ADV acquired a new position in shares of Procter & Gamble during the 2nd quarter worth approximately $37,000. Finally, Evergreen Advisors LLC purchased a new stake in Procter & Gamble in the 1st quarter valued at approximately $37,000. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

About Procter & Gamble

Procter & Gamble Company NYSE: PG is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company's well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.